Tag: Alnylam Pharmaceuticals
-
Brokers Set Expectations for Alnylam Pharmaceuticals, Inc.’s FY2026 Earnings (NASDAQ:ALNY)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Research analysts at Zacks Research issued their FY2026 earnings estimates for Alnylam Pharmaceuticals in a report released on Thursday, March 7th. Zacks Research analyst A. Chakraborty forecasts that the biopharmaceutical company will earn $2.69 per share for the year. The consensus estimate for Alnylam Pharmaceuticals’ current full-year ...